Fluorine F 18 Sodium Fluoride and Fludeoxyglucose F 18 Combined Positron Emission Tomography/Computed Tomography Scan in Diagnosing Patients with Malignant Neoplasms

This pilot research trial studies fluorine F 18 sodium fluoride (F-18 NaF) and fludeoxyglucose F 18 (F-18 FDG) combined positron emission tomography (PET)/computed tomography (CT) scan in diagnosing patients with malignant neoplasms. Diagnostic procedures, such as combined F-18 NaF/F-18 FDG PET/CT scan, may help find and diagnose cancer. It is not yet known whether F-18 NaF/F-18 FDG combined PET/CT scan is more effective than F-18 NaF or F-18 FDG PET/CT scans performed separately in diagnosing cancer.

Inclusion Criteria

Patient understands and is willing to sign an informed consent voluntarily.
Patient with a known diagnosis of cancer.

Exclusion Criteria

Patients who cannot complete a PET/CT scan.
Patient is pregnant or nursing.
Healthy volunteers.
Patients participating in other research studies.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT00725387.

PRIMARY OBJECTIVES:

I. Testing the hypothesis that the adjunctive combination of F-18 NaF and F-18 FDG in a single PET/CT scan is feasible.

SECONDARY OBJECTIVES:

I. Evaluating F-18 NaF and F-18 FDG single PET/CT scan versus (vs.) F-18 NaF PET/CT and F-18 FDG PET/CT performed separately.

II. Evaluating imaging protocols’ performance and reliability.

OUTLINE:

Patients undergo PET/CT imaging with intravenous (IV) F-18 NaF, PET/CT imaging with IV F-18 FDG, and then combined IV F-18 and F-18 FDG followed by PET/CT imaging over the course of 1 week.

Trial PhaseNo phase specified

Trial Typediagnostic

Lead OrganizationStanford Cancer Institute Palo Alto

Principal InvestigatorAndrei Iagaru

Primary IDVAR0024
Secondary IDsNCI-2011-00804, 9434, 98043
ClinicalTrials.gov IDNCT00725387

Fluorine F 18 Sodium Fluoride and Fludeoxyglucose F 18 Combined Positron Emission Tomography/Computed Tomography Scan in Diagnosing Patients with Malignant Neoplasms

Inclusion Criteria

Exclusion Criteria

Have a question?
We're here to help

Which trials are right for you?

Fluorine F 18 Sodium Fluoride and Fludeoxyglucose F 18 Combined Positron Emission Tomography/Computed Tomography Scan in Diagnosing Patients with Malignant Neoplasms

Description

Eligibility Criteria

Locations & Contacts

Trial Objectives and Outline

Trial Phase & Type

Lead Organization

Trial IDs

Have a question?We're here to help

Which trials are right for you?

Have a question?
We're here to help